Document ID: chunk:federal_register_of_legislation:F2024N01003:schedule:2
Version: federal_register_of_legislation:F2024N01003
Segment Type: schedule
Provision Reference: sch 2
Character Range: 3236–4825

Schedule 2—Amendments— Additional designated brands effective from 1 February 2025

National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023

  1  Section 5 (after table item dealing with the brand Isoleucine 50 of the drug Isoleucine with carbohydrate in the form Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine 50))
Insert:
APO-Levetiracetam      Levetiracetam  Oral solution 100 mg per mL, 300 mL  Oral
Keppra                 Levetiracetam  Oral solution 100 mg per mL, 300 mL  Oral
Kerron                 Levetiracetam  Oral solution 100 mg per mL, 300 mL  Oral
Levetiracetam GH       Levetiracetam  Oral solution 100 mg per mL, 300 mL  Oral
Levetiracetam-AFT      Levetiracetam  Oral solution 100 mg per mL, 300 mL  Oral
APO-Levetiracetam      Levetiracetam  Tablet 1 g                           Oral
Keppra                 Levetiracetam  Tablet 1 g                           Oral
Kevtam 1000            Levetiracetam  Tablet 1 g                           Oral
Levactam               Levetiracetam  Tablet 1 g                           Oral
Levetiracetam GH       Levetiracetam  Tablet 1 g                           Oral
Levetiracetam Mylan    Levetiracetam  Tablet 1 g                           Oral
Levetiracetam SZ       Levetiracetam  Tablet 1 g                           Oral
Levetiracetam Viatris  Levetiracetam  Tablet 1 g                           Oral
Levi 1000              Levetiracetam  Tablet 1 g                           Oral
NOUMED LEVETIRACETAM   Levetiracetam  Tablet 1 g                           Oral